PDK1‐stabilized LncRNA SPRY4‐IT1 promotes breast cancer progression via activating NF‐κB signaling pathway

Abstract

Pyruvate dehydrogenase kinase 1 (PDK1) is a widely known glycolytic enzyme, and some evidence showed that PDK1 promoted breast cancer by multiple approaches. However, very few lncRNAs have been identified to be associated with PDK1 in breast cancer in previous research. In this study, we found that lncRNA sprouty4‐intron transcript 1 (SPRY4‐IT1) was regulated by PDK1 with correlation analysis, and PDK1 upregulated SPRY4‐IT1 remarkably in breast cancer cells, as PDK1 interacted with SPRY4‐IT1 in the nucleus and significantly enhanced the stability of SRPY4‐IT1. Furthermore, SPRY4‐IT1 was highly expressed in breast cancer, significantly promoted the proliferation and inhibited apoptosis of breast cancer cells. In terms of mechanism, SPRY4‐IT1 inhibited the transcription of NFKBIA and the expression of IκBα, thus promoting the formation of p50/p65 complex and activating NF‐κB signaling pathway, which facilitated survival of breast cancer cells. Therefore, our finding reveals that PDK1/SPRY4‐IT1/NFKBIA axis plays a crucial role that promoting tumor progression, and SPRY4‐IT1 knockdown incombined with PDK1 inhibitor is promising to be a new therapeutic strategy in breast cancer.

EZH2: A Critical Competing Endogenous RNA in Cancer Research - A Scoping Review

“…For instance, it is overexpressed in prostate cancer and through the PI3K/AKT signaling pathway, promotes proliferation of cancerous cells (97). In breast cancer, upregulation of SPRY4-IT1 induces NF-κB signaling pathway by which promotes cell proliferation and inhibits apoptosis (98).…”